The 33rd Annual UCSF Rheumatology Board Review and Clinical Update presents major clinical topics in the field of Rheumatology to assist physicians preparing for the American Board of Internal Medicine(ABIM) Subspecialty Examination in Rheumatology, and the practicing clinician seeking to update their knowledge and care for rheumatology patients. The course overall focuses on diagnosis and treatment of rheumatic disease, disease-management problems and key advances in practice over the past 10 years.
* Date of Original Release: August 21-23, 2025
LEARNING OBJECTIVES
At the conclusion of this activity, the participant will be able to:
- Apply current, evidence-based, standards of care to rheumatic diseases (including rheumatoid arthritis, systemic lupus erythematosus, other systemic, autoimmune diseases, autoinflammatory diseases, seronegative arthritis, osteoarthritis, osteoporosis, crystalline arthritis, and soft tissue pain syndromes);
- Improve diagnostic accuracy by application of best available recent data and expert guidance;
- Refine, optimize and monitor rheumatic disease treatments based on new knowledge of efficacy and safety;
- Adopt newly approved treatments appropriately based on the latest medical evidence;
- Refine approach to pain control based on the latest evidence;
- Increase utilization of self-assessment.
33RD ANNUAL UCSF RHEUMATOLOGY BOARD REVIEW AND CLINICAL UPDATE
